Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.02 HKD
−41.72 M HKD
862.59 M HKD
328.81 M
About TOT BIOPHARM INTL CO LTD
Sector
CEO
Jun Liu
Headquarters
Suzhou
Website
Founded
2009
ISIN
HK0000545266
FIGI
BBG00QQ11Q39
TOT BIOPHARM International Co. Ltd. is clinical stage biopharmaceutical company, which engages in developing and commercializing oncology drugs and therapies. Its product portfolio includes: TAB008, TOZ309, TAA013, TAE020, TAB 014, and TAC020. The company was founded on December 4, 2009 and is headquartered in Suzhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1875 is 1.89 HKD — it has increased by 8.62% in the past 24 hours. Watch TOT BIOPHARM INTL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange TOT BIOPHARM INTL CO LTD stocks are traded under the ticker 1875.
1875 stock has risen by 8.62% compared to the previous week, the month change is a 1.07% rise, over the last year TOT BIOPHARM INTL CO LTD has showed a −7.35% decrease.
We've gathered analysts' opinions on TOT BIOPHARM INTL CO LTD future price: according to them, 1875 price has a max estimate of 2.40 HKD and a min estimate of 2.40 HKD. Watch 1875 chart and read a more detailed TOT BIOPHARM INTL CO LTD stock forecast: see what analysts think of TOT BIOPHARM INTL CO LTD and suggest that you do with its stocks.
1875 reached its all-time high on Nov 8, 2019 with the price of 6.43 HKD, and its all-time low was 0.80 HKD and was reached on Aug 3, 2023. View more price dynamics on 1875 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1875 stock is 7.98% volatile and has beta coefficient of 0.37. Track TOT BIOPHARM INTL CO LTD stock price on the chart and check out the list of the most volatile stocks — is TOT BIOPHARM INTL CO LTD there?
Today TOT BIOPHARM INTL CO LTD has the market capitalization of 1.46 B, it has decreased by −6.45% over the last week.
Yes, you can track TOT BIOPHARM INTL CO LTD financials in yearly and quarterly reports right on TradingView.
TOT BIOPHARM INTL CO LTD is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
1875 net income for the last half-year is 34.20 M HKD, while the previous report showed −24.41 M HKD of net income which accounts for 240.10% change. Track more TOT BIOPHARM INTL CO LTD financial stats to get the full picture.
No, 1875 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 552.00 employees. See our rating of the largest employees — is TOT BIOPHARM INTL CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TOT BIOPHARM INTL CO LTD EBITDA is 61.01 M HKD, and current EBITDA margin is −0.12%. See more stats in TOT BIOPHARM INTL CO LTD financial statements.
Like other stocks, 1875 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TOT BIOPHARM INTL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TOT BIOPHARM INTL CO LTD technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TOT BIOPHARM INTL CO LTD stock shows the sell signal. See more of TOT BIOPHARM INTL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.